9-122750251-T-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001004453.3(OR1L6):āc.404T>Cā(p.Val135Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000198 in 1,614,130 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001004453.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OR1L6 | NM_001004453.3 | c.404T>C | p.Val135Ala | missense_variant | 2/2 | ENST00000304720.3 | NP_001004453.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OR1L6 | ENST00000304720.3 | c.404T>C | p.Val135Ala | missense_variant | 2/2 | 6 | NM_001004453.3 | ENSP00000304235.2 | ||
OR1L6 | ENST00000373684.1 | c.512T>C | p.Val171Ala | missense_variant | 1/1 | 6 | ENSP00000362788.1 |
Frequencies
GnomAD3 genomes AF: 0.000112 AC: 17AN: 152122Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000318 AC: 8AN: 251466Hom.: 0 AF XY: 0.0000147 AC XY: 2AN XY: 135900
GnomAD4 exome AF: 0.00000958 AC: 14AN: 1461890Hom.: 0 Cov.: 81 AF XY: 0.00000688 AC XY: 5AN XY: 727246
GnomAD4 genome AF: 0.000118 AC: 18AN: 152240Hom.: 0 Cov.: 31 AF XY: 0.000148 AC XY: 11AN XY: 74436
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 08, 2022 | The c.404T>C (p.V135A) alteration is located in exon 1 (coding exon 1) of the OR1L6 gene. This alteration results from a T to C substitution at nucleotide position 404, causing the valine (V) at amino acid position 135 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at